WallStreetZenWallStreetZen

NYSE: CC
Chemours Co Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

CC past earnings growth

How has CC's earnings growth performed historically?
Company
0.81%
Industry
114.55%
Market
30.93%
CC's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
CC's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
CC's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

CC past revenue growth

How has CC's revenue growth performed historically?
Company
7.08%
Industry
16.48%
Market
17.35%
CC's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CC's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CC's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CC earnings and revenue history

Current Revenue
$6.8B
Current Earnings
$578.0M
Current Profit Margin
8.5%

CC Return on Equity

Current Company
48.5%
Current Industry
24%
Current Market
184.9%
CC's Return on Equity (48.5%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CC announces earnings.

CC Return on Assets

Current Company
7.5%
Current Industry
6.6%
CC is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CC Return on Capital Employed

Current Company
15.72%
Current Industry
11.4%
CC has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CC vs Specialty Chemical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CC$6.79B$1.20B$578.00M+1.90%-1.64%
CBT$4.32B$694.00M$352.00M+8.85%+41.35%
ESI$2.55B$485.50M$187.20M+6.30%+103.57%
BCPC$942.36M$195.87M$105.37M+9.64%+3.06%
LTHM$813.20M$363.10M$273.50M+18.54%+36.14%
View Top Specialty Chemical Stocks

CC earnings dates

Next earnings date
May 1, 2023

Chemours Co Earnings & Revenue FAQ

What were CC's earnings last quarter?

On Invalid Date, Chemours Co (NYSE: CC) reported Q4 2022 earnings per share (EPS) of -$0.58, up 140.56% year over year. Total Chemours Co earnings for the quarter were -$97.00 million. In the same quarter last year, Chemours Co's earnings per share (EPS) was $1.43.

If you're new to stock investing, here's how to buy Chemours Co stock.

What was CC's earnings growth in the past year?

As of Q1 2023, Chemours Co's earnings has grown 0.81% year over year. This is 113.73 percentage points lower than the US Specialty Chemicals industry earnings growth rate of 114.55%. Chemours Co's earnings in the past year totalled $578.00 million.

What is CC's earnings date?

Chemours Co's earnings date is Invalid Date. Add CC to your watchlist to be reminded of CC's next earnings announcement.

What was CC's revenue last quarter?

On Invalid Date, Chemours Co (NYSE: CC) reported Q4 2022 revenue of $1.34 billion up 15.05% year over year. In the same quarter last year, Chemours Co's revenue was $1.58 billion.

What was CC's revenue growth in the past year?

As of Q1 2023, Chemours Co's revenue has grown 7.08% year over year. This is 9.41 percentage points lower than the US Specialty Chemicals industry revenue growth rate of 16.48%. Chemours Co's revenue in the past year totalled $6.79 billion.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.